Supervised Exercise Therapy (SET)
Treatment for Lower extremity peripheral arterial disease
Typical Dosage: 30-60 minutes, 3 times per week
Effectiveness
75%
Safety Score
95%
Clinical Trials
150
Participants
15K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
95
DangerousModerateSafe
Treatment Details
Dosage Range
30-60 minutes, 3 times per week
Time to Effect
3-6 months
Treatment Duration
Ongoing (typically 3-6 months structured program, then maintenance)
Evidence Quality
HIGHNumber Needed to Treat (NNT)
5(Treat 5 patients to see 1 additional successful outcome)
Confidence Score
92%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$500
Side Effect Mgmt:$0
Total Annual:$500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$8,000/QALY
QALYs Gained
0.1
Outcome-Based Costs
Cost per Responder
$2,857
Cost per Remission
$4,000
Supervised Exercise Therapy (SET) Outcomes
for Lower extremity peripheral arterial disease
Efficacy Outcomes
Overall Effectiveness
+75%
Response Rate
+70%
Remission Rate
+50%
Common Side Effects
Muscle soreness
+30%
Fatigue
+20%
Minor musculoskeletal injury
+5%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov